Effect of glutamine on glucose metabolism in children with Duchenne muscular dystrophy.

[1]  J. Settleman,et al.  Modulation of Rho GTPase Signaling Regulates a Switch between Adipogenesis and Myogenesis , 2003, Cell.

[2]  N. Mauras,et al.  Acute depletion of plasma glutamine increases leucine oxidation in prednisone-treated humans. , 2007, Clinical nutrition.

[3]  J. Pachl,et al.  Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients , 2006, Critical care medicine.

[4]  F. Gottrand,et al.  Resting Energy Expenditure and Energy Substrate Utilization in Children with Duchenne Muscular Dystrophy , 1996, Pediatric Research.

[5]  M. Haymond,et al.  Effect of glutamine on leucine metabolism in humans. , 1996, The American journal of physiology.

[6]  N. Mauras,et al.  Corticosteroids increase glutamine utilization in human splanchnic bed. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[7]  D. Kipnis,et al.  Measurement of “True” Glucose Production Rates in Infancy and Childhood with 6,6-Dideuteroglucose , 1977, Diabetes.

[8]  O. Bacquer,et al.  Acute Effects of Intravenous Glutamine Supplementation on Protein Metabolism in Very Low Birth Weight Infants: A Stable Isotope Study , 2002, Pediatric Research.

[9]  M. Haymond,et al.  Role of Glutamine as a Glucose Precursor in Fasting Humans , 1997, Diabetes.

[10]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[11]  M. Goddeeris,et al.  Sarcoglycan Complex , 2009, The Journal of Biological Chemistry.

[12]  E. Levy,et al.  Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. , 2003, Clinical chemistry.

[13]  Á. Robles,et al.  The effect of l-alanyl-l-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients* , 2011, Critical care medicine.

[14]  M. Stumvoll,et al.  Regulation of gluconeogenesis by glutamine in normal postabsorptive humans. , 1997, The American journal of physiology.

[15]  M. Haymond,et al.  Oral Glutamine Slows Down Whole Body Protein Breakdown in Duchenne Muscular Dystrophy , 1998, Pediatric Research.

[16]  G F Cahill,et al.  Starvation in man. , 1970, The New England journal of medicine.

[17]  R. Hankard,et al.  L-Glutamine Administration Reduces Oxidized Glutathione and MAP Kinase Signaling in Dystrophic Muscle of mdx Mice , 2008, Pediatric Research.

[18]  T J Cole,et al.  Body Mass Index variations: centiles from birth to 87 years. , 1991, European journal of clinical nutrition.

[19]  N. Mauras,et al.  Is glutamine a 'conditionally essential' amino acid in Duchenne muscular dystrophy? , 1999, Clinical nutrition.

[20]  C. Mulvey,et al.  Expression of the skeletal muscle dystrophin-dystroglycan complex and syntrophin-nitric oxide synthase complex is severely affected in the type 2 diabetic Goto-Kakizaki rat. , 2005, European journal of cell biology.

[21]  F. Gottrand,et al.  Lack of Functional Benefit with Glutamine versus Placebo in Duchenne Muscular Dystrophy: A Randomized Crossover Trial , 2009, PloS one.

[22]  S. Kurtoğlu,et al.  Homeostasis Model Assessment Is More Reliable Than the Fasting Glucose/Insulin Ratio and Quantitative Insulin Sensitivity Check Index for Assessing Insulin Resistance Among Obese Children and Adolescents , 2005, Pediatrics.

[23]  H. Nishio,et al.  Glucose, free fatty acid and ketone body metabolism in duchenne muscular dystrophy , 1990, Brain and Development.

[24]  M. Stumvoll,et al.  Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man. , 1995, The Journal of clinical investigation.

[25]  F. Gottrand,et al.  Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy. , 2006, The American journal of clinical nutrition.

[26]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[27]  F. Gottrand,et al.  Estimating body composition in children with Duchenne muscular dystrophy: comparison of bioelectrical impedance analysis and skinfold-thickness measurement. , 2006, The American journal of clinical nutrition.

[28]  M. Haymond,et al.  Muscle wasting and carbohydrate homeostasis in Duchenne muscular dystrophy , 1978, Neurology.

[29]  Myriam Nenquin,et al.  Nutrient Control of Insulin Secretion in Isolated Normal Human Islets , 2006, Diabetes.

[30]  M. Haymond,et al.  Response of glutamine metabolism to exogenous glutamine in humans. , 1995, The American journal of physiology.

[31]  J. Holst,et al.  Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. , 2009, The American journal of clinical nutrition.